EAS’s new strategic consulting service will provide solutions to companies confronting daunting product development and labeling issues by taking a holistic approach that considers a company’s marketing objectives and the current regulatory, compliance, and enforcement environment at the federal, state and local levels.
Clients will be guided through the various regulatory processes at each level of government. EAS will advise senior management on government affairs strategy, contacting agencies directly to effectuate policy changes and filing official comments as necessary. EAS will also use its extensive network of contacts to inform departments and agencies through third-party outreach efforts and build alliances to help achieve a company’s objectives.
Our consultants will be able to help address questions such as: Should your company disclose GMO ingredients, create a “non-GMO” product line, or stay the course? What are the risks of self-defining “natural” foods including the risk of class action litigation challenging such claims? How can your company make undefined claims such as “Handcrafted” while minimizing risk from federal and state regulatory authorities? How can your company prevent an FDA warning letter from triggering “pile on” actions by state attorney generals and plaintiff class action attorneys? When does compliance with FDA labeling regulations for structure/function and other claims constitute compliance with FTC enforcement policy regarding food and dietary supplement advertising? What are trending claims and how to make them while minimizing regulatory risk.
The new EAS group would also be available to write custom reports detailing how new FDA rules affect claims made by a company for specific brands.